Ethanol metabolism and ROS are required for steatosis and HSC activation. (A) Quantification of whole-mount oil red O staining in 120 hpf larvae that were either untreated/uninjected (N/T), or injected with 4–6 nl of 0.1 mM cyp2y3 morpholino solution at the one- to four-cell stage (0 hpf), or pre-treated with 100 μM CMZ, 1 mM 4MP, 125 μM AA, 20 μM NAC at 94 hpf and then exposed to 0 or 350 mM ethanol at 96 hpf for 24 hours. Note that, although each of these treatments did not affect the spontaneous steatosis levels, they significantly reversed the rate of ethanol-induced steatosis. ***P<0.0001 by Fisher’s exact test. (B,C) qPCR analysis of Srebp1 (B) and Srebp2 (C) target genes in cDNA isolated from the livers of untreated larvae or larvae exposed to 350 mM ethanol alone or co-treated with CMZ, 4MP, AA or NAC for 24 hours from six different clutches. Data are represented as mean fold changes to untreated samples with s.e.m. (D) Ethanol-induced HSC activation is partially rescued by CMZ. The percent of larvae with an altered HSC phenotype is an indication of activation, including laminin secretion (i.e. altered morphology + laminin). Over 70% of untreated control and CMZ-treated larvae have a normal HSC morphology with complex processes and no laminin deposition in the liver, whereas only 11% of larvae have some HSCs with a normal phenotype. Co-treatment of CMZ and ethanol increases the percent of larvae with normal HSCs to 42%. The number of larvae analyzed for each condition is indicated in parenthesis on top of each bar. (E) Working model illustrating that ethanol can generate ROS either through Cyp2-mediated metabolism (via acetaldehyde) or through altering mitochondrial metabolism and that high ROS levels directly cause protein damage. Together, these lead to unfolded protein accumulation in the ER, UPR induction and, by an as-yet-unknown mechanism, steatosis.